Understanding how a specific enzyme affects melanoma growth and spread

Investigating the role of GAPDHS in melanoma metabolism and metastasis

NIH-funded research Ut Southwestern Medical Center · NIH-10873245

This study is looking at how a specific enzyme called GAPDHS affects the growth and spread of melanoma, a serious skin cancer, to see if it can help predict how the cancer will progress in patients and improve treatment options.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center NIH-funded
Lab location1 site (Dallas, United States)
Project IDNIH-10873245 on NIH RePORTER

What this research studies

This research investigates the role of the enzyme GAPDHS in the metabolism and spread of melanoma, a serious form of skin cancer. By studying how GAPDHS influences cancer cell behavior in various environments, the research aims to uncover the metabolic changes that allow melanoma to thrive and spread to other organs. The team will use patient-derived models to explore whether GAPDHS can serve as a biomarker for predicting tumor progression in melanoma patients. The findings could lead to new insights into how to better manage and treat melanoma.

Who could benefit from this research

Good fit: Ideal candidates for this research are melanoma patients who are undergoing treatment or monitoring for tumor progression.

Not a fit: Patients with non-melanoma skin cancers or those who are not currently diagnosed with melanoma may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved methods for predicting melanoma progression and potentially new therapeutic targets.

How similar studies have performed: Other research has shown promising results in understanding metabolic pathways in cancer, suggesting that this approach could yield valuable insights.

Where this research is happening

Dallas, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancers
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.